Lack of tumor promoting effects of KCB-1, a recombinant human basic fibroblast growth factor, on two-stage skin carcinogenesis in female CD-1 (ICR) mice

Cancer Letters

Volumn 105, Issue 2, 1996, Pages 195-202

  Tanaka, Hikaru ^a   Takesada, Yasuko ^a   Shibata, Masa Aki ^a   Kawabe, Mayumi ^a   Sano, Masashi ^a   Tamano, Seiko ^a   Sugimoto, Hajime ^b   Nakamura, Toshiyuki ^b   Hagiwara, Akihiro ^a  

^a Daiyukai Research Institute for Medical Science   (Japan)

^b KAKEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Basic fibroblast growth factor; CD 1 (ICR) mice; Injury; KCB 1; Skin two stage carcinogenesis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN PAPILLOMA; TUMOR PROMOTION;

EID: 0030564983     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04280-2     Document Type: Article

References (34)

1. [1] Gospodarowicz, D. (1974) Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature, 249, 123-127.
2. [2] Gospodarowicz, D., Ferrara, N., Schweigerer, L. and Neufeld, G. (1987) Structural characterization and biological functions of fibroblast growth factor. Endocr. Rev., 8, 95-114.
3. [3] Saksela, O., Moscatelli, D. and Rifkin, D.B. (1987) The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell Biol., 105, 957-963.
4. [4] Sato, Y. (1993) Function of FGF in angiogenesis. Mol. Med., 30, 986-993 (in Japanese).
5. [5] Baird, A., Esch, F., Mormède, P., Ueno, N., Ling, N., Bohlen, P., Ying, S.-Y., Wehrenberg, W.B. and Guillemin, R. (1986) Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog. Horm. Res., 42, 143-205.
6. [6] Baird, A. and Ling, N. (1987) Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem. Biophys. Res. Commun., 142, 428-435.
7. [7] O'Keefe, E.J., Chiu, M.L. and Payne, R.E.J. (1988) Stimulation of growth of keratinocytes by basic fibroblast growth factor. J. Invest. Dermatol., 90, 767-769.
8. [8] Winkles, J.A., Peifley, K.A. and Friesel, R.E. (1992) Tumor promoters induce basic fibroblast growth factor gene expression in human dermal fibroblasts. Cancer Res., 52, 1040-1043.
9. [9] Schultz-Hector, S. and Haghayegh, S. (1993) b-Fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res., 53, 1444-1449.
10. [10] Fujiki, H., Suganuma, M., Suguri, H., Yoshizawa, S., Takagi, K., Uda, N., Wakamatsu, K., Yamada, K., Murata, M., Yasumoto, T. and Sugimura, T. (1988) Diarrhetic shellfish toxin, dinophysistoxin-l, is a potent tumor promoter on mouse skin. Jpn. J. Cancer Res. (Gann), 79, 1089-1093.
11. [11] Uda, N., Fujiki, H. and Sugimura, T. (1988) Absence of tumor promoting activity of human epidermal growth factor. Proc. Jpn. Cancer Assoc., 48, 189.
12. [12] Takahashi, M., Sato, H., Toyoda, K., Furukawa, F., Imaida, K., Hasegawa, R. and Hayashi, Y. (1989) Sodium o-phenylphenate (OPP-Na) promotes skin carcinogenesis in CD-1 female mice initiated with 7,12-dimethylbenz[a]-anthracene. Carcinogenesis, 10, 1163-1167.
13. [13] Aldaz, C.M., Conti, C.J., Gimenez, I.B., Slaga, T.J. and Klein-Szanto, A.J.P. (1985) Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Cancer Res., 45, 2753-2759.
14. [14] Argyris, T.S. (1985) Regeneration and the mechanism of epidermal tumor promotion. CRC Crit. Rev. Toxicol., 14, 211-258.
15. [15] Klein-Szanto, A.J.P. and Slaga, T.J. (1981) Numerical variation of dark cells in normal and chemically induced hyperplastic epidermis with age of animal and efficiency of tumor promoter. Cancer Res., 41, 4437-4440.
16. [16] Naito, M., Naito, Y. and DiGiovanni, J. (1987) Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents. Carcinogenesis, 8, 1807-1815.
17. [17] O'Brien, T.G. (1976) The induction of omithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res., 36, 2644-2653.
18. [18] Raick, A.N. (1973) Ultrastructural, histological, and biochemical alterations produced by 12-O-tetradecanoylphorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion. Cancer Res., 33, 269-286.
19. [19] Diwan, B.A., Ward, J.M., Rice, J.M., Colburn, N.H, and Spangler, E.F. (1985) Tumor-promoting effects of di(2-ethylhexyl)phthalate in JB6 mouse epidermal cells and mouse skin. Carcinogenesis, 6, 343-347.
20. [20] Meyer, S.A., Kim, T.-W., Moser, G.J., Monteiro-Riviere, N.A. and Smart, R.C. (1994) Synergistic interaction between the non-phorbol ester-type promoter mirex and 12-O-tetradecanoylphorbol-13-acetate in mouse skin tumor promotion. Carcinogenesis, 15, 47-52.
21. [21] Sharkey, N.A., Hennings, H., Yuspa, S.H. and Blumberg, P.M. (1989) Comparison of octahydromezerein and mezerein as protein kinase C activators and as mouse skin tumor promoters. Carcinogenesis, 10, 1937-1941.
22. [22] Ward, J.M., Rehm, S., Devor, D., Hennings, H. and Wenk, M.L. (1986) Differential carcinogenic effects of intraperitoneal initiation with 7,12-dimethylbenz(a)anthracene or urethane and topical promotion with 12-O-tetradecanoyl-phorbol-13-acetate in skin and internal tissues of female SENCAR and BALB/c mice. Environ. Health Perspect., 68, 61-68.
23. [23] Ward, J.M., Quander, R., Devor, D., Wenk, M.L. and Spangler, E.F. (1986) Pathology of aging female SENCAR mice used as controls in skin two-stage carcinogenesis studies. Environ. Health Perspect., 68, 81-89.
24. [24] Kaken (1991) Three-month repeated dose toxicity study of KCB-1 in rats. Kaken Pharmaceutical Co., Ltd., Technical Office Report.
25. [25] Sugimoto, T., Nakano, Y., Nakamura, T., Nagata, T., Tuzuku, Y., Saito, K., Okuzumi, J., Aoike, A., Kawai, K. and Nishino, H. (1993) Effect of recombinant human basic fibroblast growth factor on skin tumor formation in 7,12-dimethylbenz[a]anthracene-initiated mice. J. Toxicol. Sci., 18, 359.
26. [26] Sato, H., Toyoda, K., Furukawa, F., Okamiya, H., Shimoji, N., Hasegawa, R., Takahashi, M., Hayashi, Y. and Miyakawa, Y. (1988) Effects of 9 mutagenic pyrolysates, 5 foodstuffs, 4 anti-tumor drugs and 6 heavy metals in a two-stage mouse skin model. J. Toxicol. Pathol., 1, 39-45 (in Japanese).
27. [27] Hennings, H. and Boutwell, R.K. (1970) Studies on the mechanism of skin tumor promotion. Cancer Res., 30, 312-320.
28. [28] Argyris, T.S. and Slaga, T.J. (1981) Promotion of carcinomas by repeated abrasion in initiated skin of mice. Cancer Res., 41, 5193-5195.
29. [29] Argyris, T.S. (1982) Epidermal tumor promotion by regeneration. In: Carcinogenesis: a Comprehensive Survey, Vol. 7, Cocarcinogenesis and Biological Effects of Tumor Promoters, pp. 43-48. Editors: E. Hecker, N.E. Fusenig, W. Kunz, F. Marks and H.W. Thielmann. Raven Press, New York.
30. [30] Marks, F., Berry, D.L., Bertsch, S., Fürstenberger, G. and Richter, H. (1982) On the relationship between epidermal hyperproliferation and skin tumor promotion. In: Carcinogenesis: a Comprehensive Survey, Vol. 7, Cocarcinogenesis and Biological Effects of Tumor Promoters, pp. 331-346. Editors: E. Hecker, N.E. Fusenig, W. Kunz, F. Marks and H.W. Thielmann. Raven Press, New York.
31. [31] Maita, K., Hirano, M., Harada, T., Mitsumori, K., Yoshida, A., Takahashi, K., Nakashima, N., Kitazawa, T., Enomoto, A., Inui, K. and Shirasu, Y. (1988) Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol. Pathol., 16, 340-349.
32. [32] Ball, J.K. (1968) Role of bone marrow in induction of thymic lymphomas by neonatal injection of 7,12-dimethylbenz[a]anthracene. J. Natl. Cancer Inst., 41, 553-558.
33. [33] Rappaport, H. and Baroni, C. (1962) A study of the pathogenesis of malignant lymphoma induced in the Swiss mouse by 7,12-dimethylbenz[a]anthracene injected at birth. Cancer Res., 22, 1067-1074.
34. [34] Shisa, H. and Nishizuka, Y. (1971) Determining role of age and thymus in pathology of 7,12-dimethylbenz[a]anthracene-induced leukemia in mice. Gann, 62, 407-412.